Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]

Post diagnosis aspirin improves survival in all gastrointestinal cancers

Ms Martine Frouws - Leiden University Medical Center, Leiden, Netherlands

Post diagnosis aspirin improves survival in all gastrointestinal cancers ( Ms Martine Frouws - Leiden University Medical Center, Leiden, Netherlands )

PD-L2 expression and its relevance to anti-PD-1 therapy in cancer

Dr Jennifer Yearley - Merck Research Labs, Biologics Discovery, Palo Alto, USA

PD-L2 expression and its relevance to anti-PD-1 therapy in cancer ( Dr Jennifer Yearley - Merck Research Labs, Biologics Discovery, Palo Alto, USA )

COMBI-V: Melanoma survival improved by targeted drug combination

Prof Caroline Robert - Institute Gustave Roussy, Villejuif, France

COMBI-V: Melanoma survival improved by targeted drug combination ( Prof Caroline Robert - Institute Gustave Roussy, Villejuif, France )

Prostate highlights from ECC 2015

Prof Noel Clarke and Dr Bertrand Tombal

Prostate highlights from ECC 2015 ( Prof Noel Clarke and Dr Bertrand Tombal )

Cabozantinib improves advanced kidney cancer survival: METEOR trial results

Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

Cabozantinib improves advanced kidney cancer survival: METEOR trial results ( Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

Melanoma immunotherapy latest and TVEC plus pembrolizumab

Dr Georgina Long - University of Sydney, Sydney, Australia

Melanoma immunotherapy latest and TVEC plus pembrolizumab ( Dr Georgina Long - University of Sydney, Sydney, Australia )

NETTER-1: Targeted radionuclide therapy improves PFS in mid-gut NETs

Prof Philippe Ruszniewski - Paris Diderot University, Paris, France

NETTER-1: Targeted radionuclide therapy improves PFS in mid-gut NETs ( Prof Philippe Ruszniewski - Paris Diderot University, Paris, France )

RADIANT-4: Results of international trial show promise in the treatment of...

Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA

RADIANT-4: Results of international trial show promise in the treatment of neuroendocrine tumours ( Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA )

Mid-gut NETs respond to targeted radionuclide therapy: NETTER-1 results

Prof Philippe Ruszniewski - Paris Diderot University, Paris, France

Mid-gut NETs respond to targeted radionuclide therapy: NETTER-1 results ( Prof Philippe Ruszniewski - Paris Diderot University, Paris, France )

Comment: New immunotherapy options for kidney cancer

Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium

Comment: New immunotherapy options for kidney cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )

Tailoring treatment strategies in prostate cancer: expert insight

Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu

Tailoring treatment strategies in prostate cancer: expert insight ( Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu )

CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated...

Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA

CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated advanced kidney cancer ( Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA )

More from ecancer